This paper provides an alternative approach to penalized regression for model selection in the context of high-dimensional linear regressions where the number of covariates is large, often much larger ...

Would you do it again? The perspectives of patients as they receive and recover from adjuvant therapy for stage II/III colon cancer. Background: Our previous work (Dhadda AS, et al. Clinical Oncology.

Phase IIa trial of chimeric antigen receptor modified T cells directed against CD19 (CTL019) in patients with relapsed or refractory CD19+ lymphomas. Combination of everolimus with R-CHOP (ever R-CHOP ...